Elsevier

Neurobiology of Stress

Volume 13, November 2020, 100237
Neurobiology of Stress

Forebrain overexpression of type 1 adenylyl cyclase promotes molecular stability and behavioral resilience to physical stress

https://doi.org/10.1016/j.ynstr.2020.100237Get rights and content
Under a Creative Commons license
open access

Abstract

The ability to cope with stress is essential for emotional stability and mental health. It is also hypothesized that factors promoting resilience to stress may offer treatment strategies for maladaptive disorders such as anxiety and depression. Here, we find that physical restraint reduces the expression of type 1 adenylyl cyclase (Adcy1), a neurospecific synaptic enzyme that positively regulates the cAMP signaling cascade. Conversely, an increase of forebrain Adcy1 expression in transgenic mouse (i.e., Adcy1tg mouse) predisposes individuals to molecular stability and behavioral resilience. Transgenic overexpression of Adcy1 prevents the physical restraint-induced down-regulation of brain-derived neurotrophic factor (BDNF) and neuropeptide Y (NPY). Further, Adcy1tg mice maintain regular locomotive activity in novelty exploration and voluntary wheel running following physical restraint. Adcy1tg mice show higher corticosterone and lower basal glucocorticoid receptor (GR) expression, along with a higher MR (mineralocorticoid receptor) to GR ratio in the hippocampus. Further, Adcy1tg mice show reduced immobility under acute physical stress conditions in the forced swimming test and are more sensitive to the antidepressant desipramine. Our results demonstrate a novel function of Adcy1 in stress coping and suggest Adcy1 as a potential target to antagonize stress vulnerability and promote antidepressant efficacy.

Keywords

Antidepressant
Corticosterone
Glucocorticoid receptor
Brain-derived neurotrophic factor
Physical restraint
Type I adenylyl Cyclase
Stress resilience

Cited by (0)

1

These authors contributed equally.

2

Current address: Department of Anatomy, Wonkwang University School of Medicine, Iksan, Jeonbuk 570-749, South Korea.

3

Current address: Institute of Molecular and Clinical Medicine, Kunming Medical University, Kunming, 650500, China.